CN114269723A - 吡嗪-2(1h)-酮类化合物的d晶型及其制备方法 - Google Patents
吡嗪-2(1h)-酮类化合物的d晶型及其制备方法 Download PDFInfo
- Publication number
- CN114269723A CN114269723A CN202080054561.3A CN202080054561A CN114269723A CN 114269723 A CN114269723 A CN 114269723A CN 202080054561 A CN202080054561 A CN 202080054561A CN 114269723 A CN114269723 A CN 114269723A
- Authority
- CN
- China
- Prior art keywords
- degrees
- compound
- formula
- preparation
- crystal form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
公开了一种吡嗪‑2(1H)‑酮类化合物的晶型及其制备方法,具体公开了式(ⅠI)化合物及其晶型的制备方法。
Description
PCT国内申请,说明书已公开。
Claims (10)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019107311061 | 2019-08-08 | ||
CN201910731106 | 2019-08-08 | ||
CN2019110599426 | 2019-11-01 | ||
CN201911059942 | 2019-11-01 | ||
PCT/CN2020/106901 WO2021023195A1 (zh) | 2019-08-08 | 2020-08-04 | 吡嗪-2(1h)-酮类化合物的d晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114269723A true CN114269723A (zh) | 2022-04-01 |
CN114269723B CN114269723B (zh) | 2023-09-12 |
Family
ID=74503848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080054561.3A Active CN114269723B (zh) | 2019-08-08 | 2020-08-04 | 吡嗪-2(1h)-酮类化合物的d晶型及其制备方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US11597722B2 (zh) |
EP (1) | EP4011869B1 (zh) |
JP (1) | JP7200437B2 (zh) |
CN (1) | CN114269723B (zh) |
ES (1) | ES2968388T3 (zh) |
WO (1) | WO2021023195A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021023192A1 (zh) * | 2019-08-08 | 2021-02-11 | 漳州片仔癀药业股份有限公司 | 吡嗪-2(1h)-酮类化合物的a晶型和b晶型及其制备方法 |
CN114174271B (zh) * | 2019-08-08 | 2023-09-12 | 漳州片仔癀药业股份有限公司 | 吡嗪-2(1h)-酮类化合物的c晶型和e晶型及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101468965A (zh) * | 2003-03-24 | 2009-07-01 | 默克公司 | 联芳基取代的6元杂环钠通道阻滞剂 |
CN104540809A (zh) * | 2012-07-11 | 2015-04-22 | 蓝印药品公司 | 成纤维细胞生长因子受体的抑制剂 |
WO2017070708A1 (en) * | 2015-10-23 | 2017-04-27 | Array Biopharma, Inc. | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases |
CN107438607A (zh) * | 2015-02-20 | 2017-12-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2936627T3 (es) | 2018-02-08 | 2023-03-21 | Zhangzhou Pien Tze Huang Pharm | Compuesto de pirazina-2(1H)-cetona como inhibidor de FGFR |
WO2021023193A1 (zh) * | 2019-08-08 | 2021-02-11 | 漳州片仔癀药业股份有限公司 | 吡嗪-2(1h)-酮类化合物的制备方法 |
WO2021023192A1 (zh) * | 2019-08-08 | 2021-02-11 | 漳州片仔癀药业股份有限公司 | 吡嗪-2(1h)-酮类化合物的a晶型和b晶型及其制备方法 |
CN114174271B (zh) * | 2019-08-08 | 2023-09-12 | 漳州片仔癀药业股份有限公司 | 吡嗪-2(1h)-酮类化合物的c晶型和e晶型及其制备方法 |
-
2020
- 2020-08-04 US US17/633,299 patent/US11597722B2/en active Active
- 2020-08-04 ES ES20850461T patent/ES2968388T3/es active Active
- 2020-08-04 JP JP2022507756A patent/JP7200437B2/ja active Active
- 2020-08-04 EP EP20850461.3A patent/EP4011869B1/en active Active
- 2020-08-04 WO PCT/CN2020/106901 patent/WO2021023195A1/zh unknown
- 2020-08-04 CN CN202080054561.3A patent/CN114269723B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101468965A (zh) * | 2003-03-24 | 2009-07-01 | 默克公司 | 联芳基取代的6元杂环钠通道阻滞剂 |
CN104540809A (zh) * | 2012-07-11 | 2015-04-22 | 蓝印药品公司 | 成纤维细胞生长因子受体的抑制剂 |
CN107438607A (zh) * | 2015-02-20 | 2017-12-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
WO2017070708A1 (en) * | 2015-10-23 | 2017-04-27 | Array Biopharma, Inc. | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases |
Also Published As
Publication number | Publication date |
---|---|
ES2968388T3 (es) | 2024-05-09 |
EP4011869B1 (en) | 2023-11-15 |
JP2022535625A (ja) | 2022-08-09 |
CN114269723B (zh) | 2023-09-12 |
EP4011869A4 (en) | 2022-10-12 |
US20220281853A1 (en) | 2022-09-08 |
WO2021023195A1 (zh) | 2021-02-11 |
JP7200437B2 (ja) | 2023-01-06 |
EP4011869A1 (en) | 2022-06-15 |
US11597722B2 (en) | 2023-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114174272B (zh) | 吡嗪-2(1h)-酮类化合物的制备方法 | |
CN114174271B (zh) | 吡嗪-2(1h)-酮类化合物的c晶型和e晶型及其制备方法 | |
CN114174270B (zh) | 吡嗪-2(1h)-酮类化合物的a晶型和b晶型及其制备方法 | |
CN114269723B (zh) | 吡嗪-2(1h)-酮类化合物的d晶型及其制备方法 | |
CN110023288B (zh) | 酪氨酸激酶抑制剂的晶型、盐型以及制备方法 | |
CN111479809A (zh) | 一种TGF-βRI抑制剂的晶型、盐型及其制备方法 | |
EP3896063B1 (en) | Crystalline forms of the syk inhibitor 5-fluoro-1-methyl-3-[[5-[4-(3-oxetanyl)-1-piperazinyl]-2-pyridinyl]amino]-6-(1h-pyrazol-3-yl)-2(1h)-quinolinone hydrochloride salt (1:1) | |
WO2020238802A1 (zh) | 一种c-MET/AXL抑制剂的晶型 | |
WO2019085893A1 (zh) | 一种作为fgfr4抑制剂化合物的盐型、晶型及其制备方法 | |
WO2022135580A1 (zh) | 吡啶并吡咯类化合物的晶型、制备方法及其应用 | |
KR20240004588A (ko) | 피롤로피리미딘류 화합물의 결정형 및 이의 제조 방법 | |
WO2019154192A1 (zh) | 一种3,4-二氢噻吩并[3,2-d]嘧啶类化合物的晶型及其制备方法 | |
WO2018072702A1 (zh) | 一种咪唑类化合物的晶型、盐型及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |